NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 197 filers reported holding NEVRO CORP in Q4 2019. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $401,000 | +6.4% | 8,600 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $377,000 | -40.8% | 8,600 | -2.3% | 0.00% | -50.0% |
| Q1 2022 | $637,000 | +2.4% | 8,800 | +14.7% | 0.00% | 0.0% |
| Q4 2021 | $622,000 | -44.6% | 7,672 | -20.4% | 0.00% | -50.0% |
| Q3 2021 | $1,122,000 | -59.4% | 9,642 | -42.1% | 0.00% | -63.6% |
| Q2 2021 | $2,762,000 | -17.3% | 16,663 | -30.4% | 0.01% | -26.7% |
| Q1 2021 | $3,341,000 | +421.2% | 23,952 | +420.7% | 0.02% | +400.0% |
| Q3 2020 | $641,000 | -63.5% | 4,600 | -68.7% | 0.00% | -72.7% |
| Q2 2020 | $1,756,000 | +278.4% | 14,700 | +216.8% | 0.01% | +175.0% |
| Q1 2020 | $464,000 | -79.8% | 4,640 | -82.6% | 0.00% | -78.9% |
| Q3 2019 | $2,296,000 | -0.7% | 26,710 | -25.1% | 0.02% | 0.0% |
| Q2 2019 | $2,312,000 | +29.1% | 35,652 | +24.5% | 0.02% | +46.2% |
| Q1 2019 | $1,791,000 | +22.8% | 28,644 | +12.0% | 0.01% | +62.5% |
| Q3 2018 | $1,459,000 | -25.7% | 25,576 | +4.0% | 0.01% | -20.0% |
| Q2 2018 | $1,964,000 | +691.9% | 24,585 | +759.6% | 0.01% | +400.0% |
| Q1 2018 | $248,000 | +0.4% | 2,860 | +5.7% | 0.00% | +100.0% |
| Q3 2017 | $247,000 | – | 2,707 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 622,615 | $38,920,000 | 8.04% |
| Tamarack Advisers, LP | 160,000 | $10,002,000 | 3.97% |
| Birch Run Capital Advisors, LP | 187,425 | $11,716,000 | 3.72% |
| Prosight Management, LP | 128,765 | $8,049,000 | 3.52% |
| Ratan Capital Management LP | 38,653 | $2,416,000 | 3.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 579,463 | $36,222,000 | 1.39% |
| Spark Investment Management LLC | 403,400 | $25,216,000 | 1.17% |
| Sivik Global Healthcare LLC | 50,000 | $3,126,000 | 1.15% |
| ArrowMark Colorado Holdings LLC | 1,882,009 | $117,644,000 | 1.11% |
| PFM Health Sciences, LP | 721,229 | $45,084,000 | 1.00% |